> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# BLA for Thyroid Eye Disease Therapy to Panel
- URL: https://www.fdaweb.com/bla-for-thyroid-eye-disease-therapy-to-panel/
- Published: 2019-11-20T12:00:00.000Z
- Updated: 2026-09-14T15:53:47.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145553

*Federal Register* notice: FDA has announced a 12/13 Dermatologic and Ophthalmic Drugs Advisory Committee meeting. Panel members will discuss a Horizon Pharma Ireland BLA for teprotumumab solution for intravenous use to treat active thyroid eye disease. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-25247.pdf?ref=fdaweb.com).